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Impairment of photoreceptor 
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of dystroglycanopathy
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José Martín-Nieto2,6 & Jesús Cruces1
Hypoglycosylation of α-dystroglycan (α-DG) resulting from deficiency of protein O-mannosyltransferase 
1 (POMT1) may cause severe neuromuscular dystrophies with brain and eye anomalies, named 
dystroglycanopathies. The retinal involvement of these disorders motivated us to generate a conditional 
knockout (cKO) mouse experiencing a Pomt1 intragenic deletion (exons 3–4) during the development 
of photoreceptors, mediated by the Cre recombinase expressed from the cone-rod homeobox (Crx) 
gene promoter. In this mouse, retinal α-DG was unglycosylated and incapable of binding laminin. 
Retinal POMT1 deficiency caused significant impairments in both electroretinographic recordings and 
optokinetic reflex in Pomt1 cKO mice, and immunohistochemical analyses revealed the absence of β-DG 
and of the α-DG-interacting protein, pikachurin, in the outer plexiform layer (OPL). At the ultrastructural 
level, noticeable alterations were observed in the ribbon synapses established between photoreceptors 
and bipolar cells. Therefore, O-mannosylation of α-DG in the retina carried out by POMT1 is crucial for 
the establishment of proper synapses at the OPL and transmission of visual information from cones and 
rods to their postsynaptic neurons.
Dystroglycanopathies, recently renamed as muscular dystrophies-dystroglycanopathies (MDDGs), constitute 
a heterogeneous group of recessive congenital neuromuscular diseases. These disorders are associated with a 
wide clinical spectrum, and with different grades of severity of muscular impairment, brain malformation and 
ocular abnormalities1. The main underlying cause of these symptoms is a deficiency in the process of glycosyla-
tion (mainly O-mannosylation) of dystroglycan (DG), a key component of the dystrophin-glycoprotein complex 
(DGC) in muscular2 and central nervous system (CNS) tissues3. DG acts as a nexus between the extracellular 
matrix (ECM) and the actin cytoskeleton, and is composed of two subunits: α-DG and β-DG. α-DG is an extra-
cellular protein anchored to the cell membrane by the β-DG transmembrane subunit4, while on the cytoplasmic 
side β-DG is anchored to the cytoskeletal protein dystrophin5. α-DG is a heavily glycosylated protein with the 
potential to bind, by virtue of its O-mannosyl glycans, to a large number of ECM proteins, including laminin and 
pikachurin6, the latter exclusive of the retina.
Protein O-mannosyltransferase 1 (POMT1), which is the closest phylogenetic relative of yeast Pmt47, acts 
in a heteromeric complex with POMT2 to add in the endoplasmic reticulum the initial mannose unit8 of all 
O-mannosyl glycan cores that become covalently attached to α-DG, including laminin-binding residues9. 
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Mutations in the POMT1 gene may cause severe, type A1 MDDGs (MDDGA1; OMIM #236670), including 
Walker-Warburg syndrome (WWS)10 and muscle-eye-brain disease (MEB)11, both of them coursing with signif-
icant impairments in the muscle, nervous system and eye.
Visual dysfunctions and eye morphological alterations are typical features of the most severe MDDGs. A wide 
variety of ocular anomalies have been described in POMT1-related WWS and MEB patients including retinal 
malformations, vitreoretinal dysgenesis, optic nerve hypoplasia and blindness1,12–15. In-depth studies on the role 
of POMT1 in human visual function have not been undertaken, and the constitutive knockout (KO) Pomt1 muta-
tion results in embryonic lethality in the mouse16. Consequently, its function in the retina has remained elusive. 
Instead, the role of α-DG and its O-mannosylation in the visual system has been documented in different MDDG 
Figure 1. Generation of Pomt1 retinal cKO mice. (a) Strategy for the generation of Pomt1 null alleles. The 
Pomt1 targeted allele was converted into a Pomt1 floxed allele by flippase-mediated recombination removing 
the DNA segment flanked between FRT sites. In the resulting Pomt1 floxed allele, exons 3 and 4 were flanked 
by loxP sites and were removed by Cre recombination to generate the Pomt1 null allele (Pomt1−). Arrowheads 
indicate the position of primers to discriminate Pomt1 wild-type and floxed alleles (used in b). Arrows show 
the annealing position of primers designed to assess Cre-mediated recombination in mouse retinas (used in 
Fig. 2a). The Crx-Cre gene fusion and the primers (arrows) used for its genotyping are represented at the bottom 
of the panel. (b) Results of PCR genotyping of Pomt1 alleles (upper panel) and of the Crx-Cre gene fusion 
(lower panel). This analysis allowed the discrimination between Pomt1 homozygous (wild-type or floxed) and 
heterozygous genotypes. The Crx-Cre genotyping yields a 797 bp band for the gene fusion and a 324 bp band for 
the control IL-2 gene. Genotypes defined by the results are indicated above each lane. First lane, DNA ladder. 
Uncropped gel image is presented in Supplementary Fig. S6a.
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Figure 2. Analysis of Pomt1 mRNA and protein expression, and α-dystroglycan glycosylation. (a) PCR analysis 
of Pomt1 alleles in DNA extracted from mouse retinas: Pomt1 floxed, 1,475 bp; Pomt1 wild-type, 1,392 bp; 
Pomt1 null, 545 bp. Genotypes defined by the results are indicated above each lane, abbreviated as indicated 
below. Last lane, DNA ladder. (b) Results of RT-PCR analysis designed to detect Pomt1 transcripts. PCR 
products from the wild-type (182 bp) and null (136 bp) transcripts were detected in Pomt1lox/lox and Pomt1 cKO 
mice, respectively. Gapdh mRNA (238 bp) levels showed no differences across the different mouse retinas. (c) 
qRT-PCR analysis of RNA extracted from the retinas of Pomt1lox/lox, Pomt1+/− and Pomt1 cKO mice. The left 
graph shows the levels detected (mean ± SD, n = 4) of the Pomt1 wild-type transcript, and the right graph the 
Pomt1 null transcript levels (mean ± SD, n = 4). (Statistical significances: *p = 0.0299; **p = 0.0058;  
***p < 0.001). (d) Expression of POMT1 in the mouse retina. Immunoreactivity of POMT1 in the inner 
segments of photoreceptors (green) of control mice (Pomt1lox/lox in the picture) was virtually lost in the retina 
of Pomt1 cKO mice. Nuclei were stained with DAPI (blue). Abbreviations: IS, inner segments; ONL, outer 
nuclear layer. (e) Western blotting analysis of α-DG glycosylation (VIA4-1, upper panel), laminin-binding 
www.nature.com/scientificreports/
4SCIENtIFIC RePoRTS |  (2018) 8:8543  | DOI:10.1038/s41598-018-26855-x
mouse models knocked out in different genes, such as those encoding DG17, glycosyltransferases POMGnT118,19 
and LARGE20,21, or the α-DG-interacting protein at the outer plexiform layer (OPL), pikachurin22.
In this work, we present the first report of a Pomt1 conditional knockout (cKO) mutant mouse. Using this 
novel animal model, we focused our studies on the role of α-DG and its glycosylation in the structure and phys-
iology of the retina. We show that the absence of POMT1-mediated glycosylation of α-DG in this tissue causes 
significant alterations of the ribbon synapses established between photoreceptors and their postsynaptic retinal 
neurons, at both structural and ultrastructural levels. We also demonstrate the relevance of this post-translational 
modification of α-DG for the correct transmission of visual information from the outer to the inner retina.
Results
Generation of a Pomt1 retinal cKO mouse. To generate a retinal Pomt1 cKO animal model, we designed 
a mating strategy based on the Cre/loxP system aimed at obtaining a mouse carrying homozygous Pomt1 floxed 
alleles and the Crx-Cre transgene (Pomt1lox/lox/Crx-Cre+) (Fig. 1a and Supplementary Fig. S1). In this gene 
fusion, Cre recombinase activity is driven by the promoter of the cone-rod homeobox (Crx) gene, encoding a 
transcription factor essential for the development of photoreceptors whose expression becomes induced spe-
cifically in their precursors at embryonic day (E)12.523,24. In this context, mating between floxed mice and a 
transgenic mouse line carrying the Crx-Cre gene fusion has allowed to obtain visually-impaired cKO mice ablated 
in particular genes specifically in photoreceptors, including those encoding the transcription factor Otx225 and 
dystroglycan17, among many others. Following this strategy, a mouse bearing a Pomt1 targeted gene and a flip-
pase-expressing transgenic mouse were mated to obtain mice heterozygous for the Pomt1-floxed allele (Pomt1+/lox). 
These were interbred to generate homozygous floxed Pomt1 (Pomt1lox/lox) animals and mice in parallel were 
crossed with Crx-Cre+ transgenic mice25 in order to obtain individuals heterozygous for the Pomt1 floxed allele 
and the Crx-Cre transgene (Pomt1+/lox/Crx-Cre+). The mating between Pomt1lox/lox and Pomt1+/lox/Crx-Cre+ mice 
finally generated Pomt1lox/lox/Crx-Cre+ mice (Supplementary Fig. S1). All these animals were subjected to geno-
typing by PCR analysis (Fig. 1b).
In the retina, exons 3 and 4 of Pomt1 were expected to be deleted in both alleles by Cre-promoted recombina-
tion, thus generating Pomt1 null alleles. To test this, we performed PCR analysis on retinal DNA using a primer 
pair designed to detect all possible Pomt1 alleles (Fig. 1a, arrows). This analysis revealed that only the Pomt1 null 
allele was present in the retina of Pomt1lox/lox/Crx-Cre+ mice and, therefore, that retinal Pomt1−/− conditional KO 
mice had been successfully achieved. By contrast, Pomt1+/lox/Crx-Cre+ littermates, used as controls, exhibited 
both Pomt1 floxed and null alleles (hereafter named Pomt1+/−) in the retina, whereas animals lacking the Crx-Cre 
transgene (Pomt1+/lox and Pomt1lox/lox) exhibited the original Pomt1 wild-type and/or floxed alleles in this tissue 
(Fig. 2a).
At the mRNA level, transcription of the Pomt1 null allele should result in a transcript lacking exons 3 and 4 
and containing a premature stop codon in exon 5 (Supplementary Fig. S2). We performed RT-PCR and qRT-PCR 
assays using two different primer sets able to discriminate between Pomt1 wild-type and null transcripts 
(Supplementary Fig. S2). Total RNA extracted from the retinas of Pomt1 cKO, Pomt1+/− and Pomt1lox/lox mice 
allowed us to confirm that in Pomt1 cKO mice only the Pomt1 null transcript was present, and that Pomt1lox/lox 
controls only expressed the wild-type transcript (Fig. 2b,c). In addition, heterozygous Pomt1+/− mice were found 
to exhibit both wild-type and null transcripts in the retina (Fig. 2c). One-way ANOVA showed a significant effect 
of genotype on both Pomt1 wild-type (F(2,9) = 365.036, p = 2.43·10−9) and null (F(2,9) = 61.905, p = 5.49·10−6) 
transcript levels. Post hoc test comparisons revealed significant differences among all genotypes (Fig. 2c). These 
data confirm that Cre-mediated Pomt1 exon ablation results in the synthesis of Pomt1 null transcripts in the 
retina of both Pomt1 cKO and Pomt1+/− mice. Additionally, immunostaining of POMT1 showed that, while this 
protein was located at the inner segments of photoreceptors of control mice, where the endoplasmic reticulum 
resides26, its immunoreactivity was virtually lost in the retina of cKO mice (Fig. 2d).
To study the effect of loss of POMT1 in retinal photoreceptors, we assessed the glycosylation status of 
α-DG by western blotting using the VIA4-1 antibody and laminin-binding assays, in wheat germ agglutinin 
(WGA)-enriched retinal extracts from Pomt1 cKO mice and appropriate controls with different Pomt1 genotypes. 
As shown (Fig. 2e), glycosylation of α-DG was lost together with its laminin-binding ability in Pomt1 cKO mice 
as compared with control mice containing Pomt1+ and/or Pomt1lox alleles. However, global levels of β-DG were 
unchanged in the retina of all animals studied, including Pomt1 cKO mice (Fig. 2e). These results indicate that 
loss of POMT1 in the mouse retina drastically impairs α-DG glycosylation, and thereby laminin binding.
Altered visual responses in Pomt1 cKO mice. To investigate the effect of POMT1 deficiency on 
visual function, we evaluated retinal physiology by recording electroretinographic (ERG) responses in controls 
(Pomt1+/−, Pomt1lox/lox and Pomt1+/lox mice) and in Pomt1 cKO mice. No differences were observed between the 
three control genotypes, as shown in Supplementary Fig. S3. The scotopic and photopic ERG responses elicited by 
different stimulus intensities in experimental animals are shown in Fig. 3. The ERG responses to light intensities 
of −1.5 (Fig. 3a) and 1 log cd·s·m−2 (Fig. 3b) recorded in dark-adapted Pomt1 cKO mice were severely reduced 
when compared with those of control mice. Average data on ERG b-wave amplitudes showed significant differ-
ences between control and Pomt1 cKO mice (Fig. 3d) (F(1,3) = 965.8, p = 0.00004, two-way ANOVA, Bonferroni 
ability (middle panel) and β-DG levels (lower panel) in WGA-enriched retinal extracts. Uncropped DNA gels 
and blot images are presented in Supplementary Figs S6a,b and S7. Genotype abbreviations: Pomt1+/lox refers to 
the Pomt1+/lox/Crx-Cre− genotype; Pomt1lox/lox refers to Pomt1lox/lox/Crx-Cre−; Pomt1+/− refers to Pomt1+/lox/Crx-
Cre+; and Pomt1 cKO refers to Pomt1lox/lox/Crx-Cre+.
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Figure 3. Functional retinal responses in Pomt1 cKO mice. ERG responses recorded from representative control 
(black lines) and Pomt1 cKO mice (gray lines) are shown (a–c). (a) Scotopic ERG rod response elicited by a 
−1.5 log cd∙s∙m−2 flash stimulus in control (Pomt1+/lox) and Pomt1 cKO mice. (b) Mixed ERG rod plus cone 
responses showing the negative (a-wave) and positive (b-wave) deflections elicited by a 1 log cd∙s∙m−2 flash stimulus 
under scotopic conditions in control (Pomt1+/lox) and Pomt1 cKO mice. (c) Photopic ERG cone responses elicited by 
a 1.6 log cd∙s∙m−2 flash stimulus in control (Pomt1+/lox) and Pomt1 cKO mice. (d,e) Intensity-response curve analyses. 
The b-wave response amplitude (mean ± SEM, n = 18) is represented as a function of light intensity (log cd∙s∙m−2) 
from recordings obtained under scotopic (d) or photopic (e) conditions. Individuals analyzed included 6 Pomt1lox/lox, 
6 Pomt1+/− and 6 Pomt1+/lox mice (control group), in comparison to 18 Pomt1 cKO mice (mutant group). Response 
amplitudes showed statistical differences (***p < 0.001) (two-way ANOVA) between control and Pomt1 cKO mice. 
(f) Implicit times of the b-wave averaged in rod, mixed and cone responses (mean ± SEM, n = 18; genotypes as in d,e) 
also showed statistical differences (***p < 0.001) between the two animal groups. Separate results obtained for each of 
the three control genotypes are presented in Supplementary Fig. S3.
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posttests, n = 18 animals per group). Notably, we further observed a significant delay in the scotopic and mesopic 
b-waves, as reflected by their longer implicit time (Fig. 3f; “Rod” and “Mixed”, respectively) (p = 0.0002 (rod) 
and 0.0018 (mixed), unpaired t-test, Welch’s corrected t-test). However, the a-wave amplitudes were quite sim-
ilar between Pomt1 cKO and control mice (Fig. 3b, negative deflection), thus indicating a normal function of 
photoreceptors. Altogether, these results suggest an impairment in visual signal transmission from rod photore-
ceptors to rod bipolar cells. We also assessed the ERG responses of control and Pomt1 cKO mice under photopic 
conditions (Fig. 3c,e). The ERG b-wave elicited in light-adapted control mice was higher than that in Pomt1 cKO 
mice (Fig. 3c), in the sense that a significant decrease in the b-wave amplitude was observed in Pomt1 cKO mice 
for any tested light intensity under photopic conditions (Fig. 3e) (F(1,5) = 612.3, p = 0.00004, two-way ANOVA, 
Bonferroni posttests, n = 18 animals per group), together with a significant increase in the photopic b-wave 
implicit time (Fig. 3f; “Cone”) (p < 0.0001, Student’s t-test, Welch correction). These results reflect an abnormal 
signal transmission from cone photoreceptors to cone bipolar cells in Pomt1 cKO mice.
We also evaluated the optokinetic reflex in control and Pomt1 cKO mice. Responses induced by screen rota-
tion at different spatial frequencies of alternating white and black stripes were significantly lower in Pomt1 cKO 
mice than in control animals (Fig. 4a). Contrast sensitivity in the range 0.044–0.177 cycles/degree was weaker 
(F(1,2) = 13.04, p = 0.0009, two-way ANOVA, Bonferroni posttests, n = 7 animals per group) in Pomt1 cKO mice 
than in control mice, which indicated a strong visual impairment in these animals. Finally, visual performance 
was also assessed by the water-maze test in both groups. While control animals improved their success rate along 
the testing days, Pomt1 cKO mice failed to learn due to their visual impairment (Fig. 4b). In control animals, the 
average percentage of failure in reaching the platform located below the visual stimulus decreased from the 2nd 
day of testing, reaching 10% failures by the 7th day of experimental testing. By contrast, although the percentage 
of failures also decreased in Pomt1 cKO mice, these were unable to reach the platform in 50% of trials by day 7th 
after initiating the test. Significant differences between both animal groups (F(1,3) = 51.16, p = 0.00004, two-way 
ANOVA, Bonferroni posttests, n = 7 animals per group) were observed from the 4th day after the experiment was 
started. These results reflect a remarkable impairment of visual performance in Pomt1 cKO mice.
Structural changes in the outer retina of Pomt1 cKO mice. Next, we examined the retinal morphol-
ogy of control and Pomt1 cKO mice. No obvious morphological differences in cell layer organization could be 
observed in retinal sections of Pomt1 cKO animals stained with hematoxylin plus eosin (HE), or with DAPI. 
However, the thickness of the outer nuclear layer (ONL) and the OPL was significantly less in Pomt1 cKO mice 
than in controls (Supplementary Fig. S4). To evaluate the effect of conditional knockout of Pomt1 on the struc-
ture of the OPL, we performed confocal microscopy studies using antibodies against constituent elements of 
the DGC and associated proteins. In the retina of control mice, β-DG residing in the presynaptic membrane of 
photoreceptors displayed a punctate staining pattern along the OPL (Fig. 5a), as expected, whereas in the retina 
of Pomt1 cKO mice β-DG immunoreactive dots were completely absent in this layer (Fig. 5b). Dystrophin was 
found along the OPL in both control and cKO animals, colocalizing with β-DG in the retina of control animals 
(Fig. 5c), but with a certain misalignment of immunoreactive dots in the retina of Pomt1 cKO mice (Fig. 5d) with 
respect to the normal arrangement of dystrophin puncta in control mice (Fig. 5c). Immunostaining of pikachurin 
yielded a pattern of immunoreactive dots lying adjacent to synaptic ribbons stained with antibodies to CtBP2 in 
the OPL of control mice (Fig. 5e) but, by contrast to dystrophin, pikachurin immunoreactivity was completely 
absent in Pomt1 cKO animals (Fig. 5f). Additionally, an intense fluorescence signal from β-DG and dystrophin 
was found in retinal blood vessels and the inner limiting membrane that was unchanged in the Pomt1 cKO retina 
(Supplementary Fig. S5). These results indicate that loss of POMT1 in photoreceptors does not affect the structure 
of the innermost layers of the mouse retina.
Figure 4. Visual responses in Pomt1 cKO mice. (a) Optokinetic responses of control and Pomt1 cKO mice. 
Contrast sensitivity is represented as a function of spatial frequency as the mean ± SD (n = 7). The control group 
included 3 Pomt1+/lox, 1 Pomt1lox/lox and 3 Pomt1+/− mice, and the mutant group included 7 Pomt1 cKO mice. 
Statistical differences (***p < 0.001, two-way ANOVA) were found for intermediate spatial frequencies: 0.044, 
0.088, and 0.177 cycles/degree. (b) Behavioral visual responses obtained in the water-maze test are represented. 
Left: drawing of the water-maze device where the discontinuous line depicts a representative correct response 
and the continuous line a representative failure response. Right: percent of failure responses (mean ± SEM, 
n = 7; genotypes as above) shown as a function of the testing day. Statistically significant differences 
(***p < 0.001) were observed from the 4th day of testing.
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We used antibodies against rhodopsin and cone arrestin to further examine the morphology of cells involved 
in the first synapse of the visual pathway. These photosensitive proteins were properly distributed in the outer 
segments of rods and cones, respectively, although some retraction of these structures in rods and a shortening of 
Figure 5. Expression and localization of presynaptic-terminal and associated proteins in the OPL of Pomt1 
cKO mice. Retinal sections of control (Pomt1+/lox) (a,c,e) and Pomt1 cKO (b,d,f) mice were single or double 
immunostained with antibodies against β-dystroglycan (β-DG; a–d; green), dystrophin (Dys; c,d; red), 
pikachurin (e,f; green) and CtBP2 (e,f; red). The nuclei of all sections were stained with DAPI, and are shown 
in blue on the left side of each micrograph. β-DG was absent in the OPL of Pomt1 cKO mice (b,d), although 
its expression was unchanged in retinal blood vessels as compared with control animals (a,b; arrowheads). 
Abbreviations: ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer.
www.nature.com/scientificreports/
8SCIENtIFIC RePoRTS |  (2018) 8:8543  | DOI:10.1038/s41598-018-26855-x
Figure 6. Structural alterations in outer retinal neurons of Pomt1 cKO mice. Immunohistochemical analysis 
was carried out using antibodies against rhodopsin (Rho; green), which labels the outer segments of rods, and 
cone arrestin (cArr; red), a specific marker for cones (a,b). The distribution pattern of synaptophysin (Syp; 
green), a presynaptic protein located in the axon terminals of photoreceptors, and calbindin (CB; red), which 
labels horizontal cells (c,d), are also shown. Synaptic contacts between presynaptic terminals were labeled with 
antibodies to bassoon (red), and dendrites of rod bipolar cells with antibodies to protein kinase Cα (PKCα; 
green) in the retinas of control (Pomt1+/lox) and Pomt1 cKO mice (e,f). Bipolar cell dendrite sprouting into the 
ONL was found in certain areas of the retina of mutant animals (f; arrows). Nuclei stained with DAPI are shown 
in blue on the left side of each micrograph. Abbreviations: OS, outer segment; IS, inner segment; ONL, outer 
nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer.
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Figure 7. Presynaptic and postsynaptic terminals in the OPL of control and Pomt1 cKO mice. Retinal sections 
from control (Pomt1+/lox) (a,c,e) and Pomt1 cKO (b,d,f) mice were stained with antibodies against CtBP2 (red), 
which labels synaptic ribbons of cones and rods, and with peanut agglutinin (PNA; magenta), a lectin that 
labels the base of cone pedicles. Additionally, they were immunostained for cone arrestin (cArr; a,b; green), a 
cone-specific presynaptic protein, synaptophysin (Syp; c,d; green), a presynaptic protein labeling cone pedicles 
and rod spherules, and protein kinase Cα (PKCα; e,f; green), which labels rod bipolar cells. The nuclei of all 
sections stained with DAPI are shown on the left side of each micrograph. In the retina of Pomt1 cKO mice, 
loss of normal alignment of synaptic proteins in the outer half of the OPL was observed for CtBP2 (b,d,f), Syp 
(d) and PNA (b,d,f) labeling (see insets), as compared with the OPL of control mice (a,c,e; bracket and insets). 
Besides, considerable sprouting of bipolar cell dendrites protruding into the ONL was revealed by PKCα 
immunostaining in Pomt1 cKO mice (f; arrows) as compared with control mice (e). Abbreviations: ONL, outer 
nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer.
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cone axons were observed in Pomt1 cKO mice when compared with controls (Fig. 6a,b). To investigate possible 
alterations in the structure of synapses established between photoreceptor axon terminals and their postsynaptic 
(horizontal and bipolar) cells, we performed double immunostaining using antibodies against the presynaptic 
proteins synaptophysin and bassoon, and against calbindin (a horizontal cell marker) and protein kinase C (α 
isoform, a rod bipolar cell marker). No obvious differences were observed between the retinas of control and 
Pomt1 cKO mice in the punctate immunostaining pattern of synaptophysin or in the morphology and number 
of horizontal cells (Fig. 6c,d). However, although we did not find differences in the association between the pre-
synaptic marker bassoon (Fig. 6e,f) or the postsynaptic marker mGluR6 (data not shown) and dendrites of rod 
bipolar cells, a misalignment of presynaptic terminals of photoreceptors in the OPL was observed in specific areas 
of the retina in Pomt1 cKO mice, which was associated with an abnormal sprouting of dendrites from bipolar cells 
protruding into the ONL (Figs 6f and 7f; arrows). These observations were further corroborated by fluorescent 
labeling for the synaptic-ribbon marker CtBP2, the presynaptic-vesicle protein synaptophysin, and peanut agglu-
tinin (PNA), which labels the base of cone pedicles (Fig. 7). As shown, in the retina of Pomt1 cKO mice a loss of 
the normal arrangement of synaptic proteins in the outer half of the OPL was observed upon CtBP2 (Fig. 7b,d,f) 
Figure 8. Electron microscopy images of photoreceptor axon terminals in Pomt1 cKO mice. Rod spherules 
and cone pedicles are shown from control (Pomt1lox/lox) (a–e) and Pomt1 cKO (f–j) mice. At the rod spherule 
of control mice (a), processes from horizontal cells (asterisks) were located laterally apposed to the synaptic 
ribbon (blue arrow), and dendritic processes from rod bipolar cells were located below the ribbon. By contrast, 
horizontal cell processes in Pomt1 cKO mice (f) failed to reach their proper position relative to the rod synaptic 
ribbon, and dendritic processes from rod bipolar cells were barely visible at the synaptic cleft. At the cone 
pedicle (yellow dashed line in b and g; schematized in c and h, respectively), the number of invaginations 
(synaptic complexes) was higher in control (b) than in Pomt1 cKO (g) mice, and mitochondria (green arrows) 
were more abundant near the synaptic complexes of control (b,c) than of Pomt1 cKO (g,h) mice. Details of 
the synaptic complex at cone pedicles (red boxes in b and g) are schematized in panels c and h, and shown 
at a higher magnification in d and i for control and Pomt1 cKO mice, respectively. As noticeable, the lateral 
processes from horizontal cell (asterisks) and basal process from bipolar cells exhibited a normal appearance in 
control mice (c), but seemed disorganized relative to the synaptic ribbon (blue arrows) in Pomt1 cKO mice (i). 
Drawings in e and j schematize the differences observed between cone and rod synaptic triads of control and 
Pomt1 cKO mice, respectively.
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and Syp (Fig. 7d) immunostaining, as compared with the OPL of control mice (Fig. 7a,c,e). Also, the normally 
discontinuous PNA labeling in this layer in control mice (Fig. 7a,c,e) showed a conspicuous misalignment in 
Pomt1 cKO mice (Fig. 7b,d,f).
Synaptic alterations at the OPL level were further examined by electron microscopy. At a first glance, the 
structure of synaptic complexes in the conditional mutant mice appeared abnormal (Fig. 8). In both control and 
Pomt1 cKO animals, presynaptic terminals exhibited a bar-like synaptic ribbon, but dendritic projections from 
bipolar and horizontal cells appeared to be altered in Pomt1 cKO mice. In control animals, synaptic structures in 
both rod and cone axon terminals showed a clearly normal shape, with horizontal cell processes located laterally 
opposed to the synaptic ribbon, and with bipolar cell processes pointing to the base of the ribbon (Fig. 8a–e). By 
contrast, in Pomt1 cKO mice, horizontal cell dendritic projections barely reached their location laterally to the 
synaptic ribbon, and bipolar cell dendritic projections failed to meet photoreceptor synaptic terminals (Fig. 8f–j). 
The synaptic complex was absent in those rod spherules lying most distant from the OPL. Concurrent with these 
alterations, mitochondria in both rod and cone axon terminals in Pomt1 cKO mice exhibited evident alterations, 
appearing swollen and showing a severe disruption of their cristae (see for comparison Fig. 8a,f). Also, the num-
ber of mitochondria was reduced in Pomt1 cKO mice and their distance from the synaptic complex was increased 
in cone pedicles (see for comparison Fig. 8b,g). Overall, these results reflect an abnormal organization of synapses 
between rod and cone axon terminals and their postsynaptic cells in our Pomt1 cKO mice.
Discussion
MDDGs are rare neuromuscular congenital dystrophies with a total of 18 associated genes identified so far, all 
of them related to the O-mannosylation pathway of the DG α subunit2,27. This modification is essential for link-
age via α-DG of cytoskeletal components to the ECM in muscle and brain cells, and crucial for proper synapse 
formation and function in the retina27–29. Among those genes, POMT1 encodes the first enzyme acting on the 
α-DG O-mannosylation process, and it has been shown that mutations in this gene may cause severe MDDGs, 
including WWS and MEB, usually coursing with serious ocular abnormalities13,15,30,31. The Pomt1 gene has been 
shown by our group to be expressed at the mRNA level during mouse embryogenesis in the nervous system, mus-
cle and eye16,32, coincidently with tissues mostly affected in patients with such diseases. As well, we have recently 
reported expression of Pomt1 at both mRNA and protein levels in the adult retina of the mouse and a variety of 
mammalian species33. In this context, we have proposed that POMT1 deficiency is related to ocular abnormalities 
detected in patients with these diseases32, an issue whose addressing led us to generate the Pomt1 cKO model 
reported in the present work.
Targeted disruption of MDDG-related genes like DG34, POMT116, fukutin35 or FKRP36 is lethal during early 
mouse embryogenesis, and is consistent with a properly glycosylated, and hence functional, α-DG being essential 
for the formation and integrity of Reichert’s membrane34. To overcome this problem, we generated homozy-
gous Pomt1-floxed mice, which were crossed with a transgenic mouse line carrying a Crx-Cre gene fusion. This 
transgenic line has been used to successfully generate photoreceptor-specific cKO mice in a wide variety of 
genes17,25,37–41. As a result, we obtained animals harboring a Pomt1 intragenic deletion in retinal tissue (con-
ditional Pomt1−/− genotype, or Pomt1 cKO), which at the mRNA level caused the appearance of a Pomt1 null 
transcript containing a premature stop codon. In the Pomt1 cKO retina, α-DG glycosylation was virtually lost 
together with its ability to bind laminin. Unfortunately, for lack of an appropriate antibody working in immuno-
histochemistry against α-DG (either glycosylated or core α-DG), we could not verify this result at the structural 
level on mouse retinal sections. By contrast, both α-DG properties remained in heterozygous Pomt1+/− mice, 
consistent with the recessive character of POMT1-associated MDDGs. Our Pomt1 cKO mice were thus genotypi-
cally and biochemically as expected, and POMT1 activity was shown to be crucial for interaction of retinal α-DG 
with laminin, as previously demonstrated in muscle and brain42. Furthermore, we failed to detect alterations in 
the innermost layers of the retina, or in vital organs of mice, demonstrating that the Pomt1 gene had been specif-
ically knocked out in retinal photoreceptors.
Pomt1 cKO mice display a normal a-wave, but show a clear reduction in amplitude and a longer implicit time 
of the b-wave in ERGs recorded under scotopic and photopic conditions. These results reflect an impairment of 
visual transmission from rods and cones to their postsynaptic bipolar cells, originating in the OPL at the photo-
receptors presynaptic side. This ERG dysfunction is comparable to that caused by loss of DG in the OPL17, but 
is more severe than that found in Pomgnt1 KO18,19 and Largemyd spontaneous KO mice20,21 and Pikachurin null 
mice22 in their ERG scotopic b-wave responses. The higher severity of POMT1 loss could be attributable to the 
importance of the first limiting step in α-DG O-mannosylation carried out (as a heterodimer) by POMT1 and 
POMT2 enzymes8. Indeed, these are the only two proteins simultaneously involved in the synthesis of the three 
main O-mannosylglycan structures of α-DG, designated as M1, M2 and M3 cores9.
Until now, no data were available on the effect of DG absence on the optokinetic reflex or visual behavior, 
both of which were impaired in Pomt1 cKO mice, and to a greater extent in Pikachurin KO mice22. The latter did 
not show noticeable alterations with relatively large angle stripes, but their sensitivity to small angle stripes was 
significantly impaired22,43. The decrease in information reaching retinal bipolar cells from photoreceptors may 
explain our results. Additionally, failure of learning by Pomt1 cKO mice in the water-maze test could be attributed 
to a remarkably impaired visual performance.
In similarity to DG cKO17 and Pikachurin KO22 mice, functional deficiencies in Pomt1 cKO mice were not 
accompanied by obvious malformations of retinal layers. This is in contrast to the loss of retinal laminar struc-
ture, thinner retina, retinal detachment, and decreased density of photoreceptors and ganglion cells observed 
in MDDG mouse models deficient in POMGnT118, fukutin35 or LARGE21. We evaluated potential alterations 
in DGC components at the OPL level in Pomt1 cKO mice by immunohistochemistry. β-DG and pikachurin, 
the main α-DG-interacting ECM protein, were completely absent at the OPL in Pomt1 cKO mice, although 
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the intracellular component dystrophin was unaltered. The loss of β-DG found at the OPL contrasts with the 
result that global retinal levels of β-DG were not detectably decreased by western blotting, although this could 
be accounted for, at least in part, by its immunoreactivity being unaltered in the ILM and retinal blood ves-
sels, where its expression appears predominant. Nevertheless, the absence or presence of β-DG in the OPL of 
MDDG animal models is controversial, and in this light our results are similar to those obtained in Pikachurin 
KO and Largevls mice17,21, but are at variance with other null models, such as the Pomgnt1 KO and the Largemyd 
and LargePB mice, in which β-DG was retained in this retinal layer44–46. Recently, it has been suggested that proper 
O-mannosylation of α-DG could be necessary for its proper folding, and that the lack of this post-translational 
modification would trigger its degradation in the endoplasmic reticulum47. Regarding pikachurin, its absence 
in the OPL of Pomt1 cKO mice is in concordance with results obtained in DG cKO, Pomgnt1 KO and Largemyd 
mice17,45,48. Since its encoding gene is normally expressed at the mRNA level in the retina of Pomgnt1 KO and 
Largemyd mice, but pikachurin protein is not detected by western blotting45, the latter is expected to have as well 
become degraded, upon failure of its interaction with α-DG. Taken altogether, our data strongly suggest that the 
first step in O-mannosylation of α-DG carried out by POMT1 is crucial for both the correct accumulation of 
pikachurin in the OPL and the proper localization of β-DG at the presynaptic terminals of photoreceptor cells.
A misalignment and retraction of presynaptic terminals of photoreceptors and dendritic sprouting of bipolar 
cell into the ONL were observed in immunolabeled retinal sections of Pomt1 cKO mice. These abnormalities 
were confirmed at the ultrastructural level by electron microscopy, where it was observed that dendritic processes 
of bipolar and horizontal cells were not inserted into the invaginations of ribbon synapses, resulting in a gap 
between the pre- and post-synaptic active zones. These defects have been previously associated with a delayed 
and reduced b-wave amplitude in the ERG of mutant mice impaired in different components of the DGC49, as it 
was the case for our Pomt1 cKO mice.
Electron microscopy analysis showed that mitochondria in rod and cone synaptic terminals appeared reduced 
in number and swollen, with severe disruption of their cristae. Mitochondria in the OPL are also swollen in 
Largemyd mice, which additionally show numerous, disrupted cristae in Largevls mutants21, as occurs in other 
rodent models of retinal degeneration50–52. Impaired electron transport and oxidative stress53 at the presynaptic 
terminals could consequently occur in our Pomt1 cKO mutants, as proposed for the rd10 mouse model of retinitis 
pigmentosa54.
In summary, lack of the first enzyme acting on α-DG glycosylation, POMT1, prevents the correct formation 
of synaptic complexes at the OPL, as evidenced in this work at structural and ultrastructural levels. Consequently, 
transmission of visual signals from rods and cones to their postsynaptic bipolar cells is severely impaired as a 
likely consequence of the loss of glycosylation-dependent interaction between α-DG and ECM proteins, such as 
pikachurin and laminin. Our present findings indicate that POMT1 is a key O-mannosyltransferase relevant for 
the formation and function of synapses between photoreceptors and their postsynaptic bipolar cells, its muta-
tional loss thereby mimicking a good part of the retinal pathology found in WWS and other POMT1-associated 
MDDGs.
Materials and Methods
Animal care. All procedures were performed according to the Spanish and European legislation, and exper-
iments were approved by the Ethics Committees of the Universidad Autónoma de Madrid and Universidad de 
Alcalá. Experiments were carried out in mice ranging from 3 to 5 months of age.
Generation of Pomt1 cKO mice. The mating strategy used with this purpose is schematized in 
Supplementary Fig. S1. Pomt1-targeted mouse embryonic stem cells were obtained from the EUCOMM program 
(http://www.mousephenotype.org/) and were aggregated with morulas (E2.5) from CD1 mice to generate chi-
meric animals. These were mated with wild-type mice and their offspring were genotyped for transmission of the 
Pomt1 targeted allele by PCR amplification of the lacZ sequence using primers lacZ-F and lacZ-R. To generate the 
Pomt1 floxed mouse line, transgenic mice bearing the flippase recombinase transgene (FLP) were crossed with 
mice carrying the Pomt1 targeted allele. Mice with successful flippase-mediated recombination were selected by 
PCR using primers FRT1-F and loxP2-R. This PCR reaction was used subsequently to discriminate between the 
different Pomt1 genotypes. Transgenic Crx-Cre+ mice25 were purchased from the RIKEN BioResource Center 
(http://mus.brc.riken.jp/en/). For genotyping of mice carrying the Crx-Cre transgene, we used the primers recom-
mended by RIKEN, Crx-prom3 and LCB837 (Cre2). Also, we used the control primers oIMR0042 and oIMR0043 
to amplify an interleukin-2 (IL2) gene fragment. For the assessment of intragenic Pomt1 deletion in mouse ret-
inal genomic DNA, retinas were extracted from the eyes of 5-month-old mice. DNA isolation was performed 
following the phenol/chloroform-free method described previously55. Primers Pomt1-i2-F and Pomt1-i4-R were 
used to distinguish between Pomt1 wild-type, floxed and null alleles. All primer sequences and diagnostic PCR 
products are listed in Supplementary Table S1.
RT-PCR and qRT-PCR analysis of Pomt1 transcript variants. Retinas were extracted in the presence 
of RNAlater (Ambion, Austin, TX, USA). Total RNA was obtained using the RNeasy Mini kit (Qiagen, Valencia, 
CA, USA), and reverse transcription of 150–200 ng of RNA was carried out using the qScript cDNA kit (Quanta 
Biosciences, Gaithersberg, MD, USA). For RT-PCR, we used two different primer sets to distinguish between 
the Pomt1 wild-type (E2/3-F and E4/5-R primers) and null (E2/5-F and E5-R primers) mRNA transcripts. For 
each PCR reaction, the corresponding Pomt1 primer pair was used together with control primers Gapdh-F and 
Gapdh-R.
For qRT-PCR, cDNA was obtained using the High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Foster City, CA, USA). Quantitative PCR was performed in a 7900 Fast Real-Time PCR System 
(Applied Biosystems) using the above Pomt1 primers and SYBR Green PCR Master Mix. The Actb gene was 
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used as an endogenous housekeeping gene for normalization (primers Actb-F and Actb-R). Statistical analy-
ses were performed using the SPSS software package (IBM Corp., v21.0). Differences in Pomt1 transcript levels 
between different genotypes were tested using one-way ANOVA. Both expression data were normally distrib-
uted, but the Pomt1 wild-type transcript data showed homoscedasticity and the null transcript data showed 
non-homoscedasticity. Thus, we used Bonferroni’s parametric test and the non-parametric Games-Howell test, 
respectively, for post-hoc analysis. All primer sequences and PCR product lengths are listed in Supplementary 
Tables S1 and S2.
Protein extraction and WGA glycoprotein enrichment. Eyes were enucleated and retinas extracted 
in PBS and frozen. Subsequently, they were homogenized in lysis buffer (50 mM Tris pH 8.0, 100 mM NaCl, 1% 
Triton X-100) supplemented with EDTA-free Protease Inhibitor Cocktail (Roche Applied Science, Mannheim, 
Germany), containing 0.5 μg/ml leupeptin, 1 μg/ml pepstatin and 0.1 mM PMSF. Protein quantitation was made 
using the BCA Protein Assay Kit (Pierce, Rockford, IL, USA). For WGA enrichment, 350 μg of mouse retinal 
lysate was incubated with 100 μl of WGA-agarose beads (Vector Labs, Burlingame, CA, USA) in lectin-binding 
buffer (LBB: 20 mM Tris pH 7.5, 1 mM MnCl2, 1 mM CaCl2) at 4 °C overnight. Then, the beads were washed twice 
with LBB and boiled for 5 min in Laemmli sample buffer. The eluted proteins were used for western blotting and 
laminin-binding assays.
Western blotting and laminin-binding assay. Proteins in WGA-enriched retinal extracts were sepa-
rated by SDS-PAGE on 7.5% polyacrylamide gels and transferred to PVDF membranes (Immobilon-P, Millipore; 
Darmstadt, Germany). The membranes were blocked with 3% BSA in TBST (50 mM Tris, pH 7.5, 150 mM NaCl, 
0.05% Tween-20) supplemented with 1 mM MnCl2 plus 1 mM CaCl2, and then incubated with the primary anti-
bodies described in Supplementary Table S3, in the same blocking solution at 4 °C overnight. After washing with 
TBST, the membranes were incubated with the corresponding secondary antibodies (Supplementary Table S4) at 
a 1:5,000 dilution for 1 h, and the signal was detected using ECL reagents (Pierce). For posterior laminin-binding 
assays, antibodies were stripped by incubation of the membranes at 50 °C for 30 min in a buffer containing 
100 mM β-mercaptoethanol, 2% SDS and 62.5 mM Tris, pH 6.7. Laminin-binding assays were performed as 
described previously42. Briefly, the membranes were incubated with 1.25 μg/ml laminin (L2020; Sigma-Aldrich, 
St. Louis, MO, USA) diluted in laminin-binding buffer (LamBB: 3% BSA in TBST supplemented with 1 mM 
CaCl2, 1 mM MgCl2 and 1 mM MnCl2) at 4 °C overnight. Then, they were blocked with LamBB for 1 h at room 
temperature, and thereafter sequentially incubated with an anti-laminin primary antibody and secondary anti-
bodies, as above (Supplementary Tables S3 and S4). Signals were detected using ECL reagents.
Electroretinography. Prior to ERG recording, mice were adapted to the dark overnight. Then, controls and 
Pomt1 cKO mice were anesthetized under dim red light upon injection of ketamine (95 mg/kg, i.p.) and xylazine 
(5 mg/kg, i.p.) and maintained on a heated pad at 37 °C. Pupils were dilated by topical application of 1% tropi-
camide (Alcon Cusí, S.A., El Masnou, Barcelona, Spain) and flash-induced ERG responses were recorded from 
both eyes in response to light stimuli produced with a Ganzfeld stimulator. The setup procedures were conducted 
in dim red light for ca. 10 min, after which scotopic ERG (light flashes from −4 log cd·s·m−2 to 2 log cd·s·m−2) 
were recorded. Under scotopic conditions, five to ten responses were averaged; flash intervals were set at 30 s. 
After the dark-adapted ERG recordings, the animals were light-adapted for 10 min under white rod-suppressing 
background light (100 cd·m−2), and photopic ERG (light flashes from −0.8 log cd·s·m−2 to 2.1 log cd·s·m−2) 
were recorded. Under photopic conditions, 30 to 60 responses were averaged and flash intervals were set at 1 s. 
Calibration of the flash stimulating light source was performed using a Mavo-Monitor USB Light Meter (Gossen, 
Nürenberg, Germany).
The outcome measures were the response amplitudes and implicit times of each ERG component. The ERG 
complied with the International Society for Clinical Electrophysiology of Vision (ISCEV) standards56. The 
ERG signals were amplified and band filtered between 1 and 1000 Hz with a Grass CP511 AC amplifier (Grass 
Instruments, Quincy, MA, USA). Electrical signals were digitized at 20 kHz with a Power Laboratory data acqui-
sition board (AD Instruments, Chalgrove, UK). Bipolar recordings were obtained using an Ag:AgCl mouse 
electrode fixed on a Burian-Allen corneal lens (Hansen Ophthalmic Development Lab, Coralville, IA, USA), a 
reference electrode located in the mouth, and a ground electrode located on the tail. Simultaneous recording was 
performed on both eyes. Each electrode was mounted on a coarse micromanipulator for easy positioning over the 
mouse eyes. Impedance of active and reference electrodes was less than 20 Ω.
Other analyses. The optomotor response and visual water task were evaluated as described in Supplementary 
Materials and Methods, together with immunohistochemistry and electron microscopy assays.
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